Angiogenesis Flashcards

1
Q

What are the three ways of making blood vessels?

A

Vasculogenesis – formation of new blood vessels from bone marrow progenitor cells
Angiogensis – formation of new blood vessels by sprouting from pre-existing vessels
Arteriogenesis – collateral growth of blood vessels that is dependent on shear stress and external factors like macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the main signal for angiogenesis?

A

Hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most important pro-angiogenic factor?

A

VEGF (Vascular Endothelial Growth Factor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Explain the mechanism by which hypoxia triggers angiogenesis.

A

HIF (hypoxia-inducible factor) is a transcription factor that is responsible for the expression of genes involved in angiogenesis
In normoxic conditions, HIF is bound to von Hippel Lindau protein (tumour suppressor), which inhibits HIF from promoting angiogenesis
In hypoxic conditions, HIF is not bound to von Hippel Lindau so it can regulate transcription and express genes involved in angiogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which receptor is the major mediator in VEGF-dependent angiogenesis?

A

VEGFR2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What pathway is crucial for the selection of tip cells?

A

Notch signalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens when the DLL4 ligand binds to the notch receptor?

A

The intracellular NICD domain is cleaved This then translocates to the nucleus and binds to the transcription factor RBP-J and regulates transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is another name for the notch ligand?

A

Delta-like ligand (Dll4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What effect does VEGF have on notch signalling?

A

It increases expression of Dll4
Dll4 then drives Notch signalling, which inhibits expression of VEGFR2 in the adjacent cell
Dll4 expressing tip cells develop a motile, invasive and sprouting phenotype
Adjacent stalk cells form the base of the emerging sprout and proliferate to support sprout elongation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which cell type is involved in vessel anastomosis and helping stabilise newly formed vessels by promoting tip cell fusion?

A

Macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which other cell type is recruited to help with the stabilisation ofthe newly formed vessel?

A

Pericytes (mural cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which cell adhesion molecules are essential for vessel stabilisation and quiescence?

A

VE-Cadherin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What growth factor do pericytes produce that is important for stabilisation of new blood vessels?

A

Angiopoietin 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which important signalling pathway modulates the activation and return to quiescence of endothelial cells?

A

Angiopoietin-Tie2 signalling pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the actions of angiopoietin 1.

A

Ang 1 promotes quiescence in the blood vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the actions of angiopoietin 2.

A

Ang 2 is an antagonist and gets released when you need to form a new vessel or when you need to respond to inflammation/vasculature needs to be destabilised

17
Q

What is the name given to the point at which a tumour begins to initiate signals to generate new vasculature?

A

Angiogenic switch- point at which tumours can no longer just rely on oxygen and nutrients from host vasculature so need a new vessel structure to supply them. Normally >1mm3

18
Q

What are some of the issues with tumour blood vessels?

A

They are not properly formed because the signals are not physiological
Vessels can be irregularly shaped, distended, tortuous
Leaky and haemorrhagic etc
Haemorrhage is common in tumours.

19
Q

What is the aim of anti-angiogenic therapy in cancer?

A

To normalise tumour blood vessels to reduce hypoxia and improve efficiency of drug delivery

20
Q

What are the consequences of being too aggressive with anti-angiogenic therapy?

A

This can make the tumour blood supply inadequate for the delivery of drugs

21
Q

What is avastin?

A

Anti-VEGF humanised mouse antibody
Also called bevacizumab
It’s the soluble part of a VEGFR that mops up VEGF

22
Q

What are the side effects of avastin?

A
GI perforation  
Hypertension 
Proteinuria 
Venous thrombosis  
Haemorrhage
23
Q

What are the two main methods of unconventional resistance to VEGF blockade?

A

Tumour adopts evasive strategy – adapts to bypass the angiogenic blockade
Intrinsic or pre-existing difference – a tumour may not have been particularly sensitive to VEGF in the first place

24
Q

What did avastin start getting used for other than cancer?

A

Age-related macular degeneration (AMD)

25
Q

Which cell leads angiogenesis

A

Tip

26
Q

Which cell is notch ligand and receptor found on

A

Ligand- tip

Receptor- stalk

27
Q

What maintains quiescence in stable blood vessels

A

Dll4 and notch signalling

28
Q

Role of macrophages in angiogenesis

A

Carve out tunnels in ECM providing avenues for capillary infiltration

29
Q

Which cell cell junctions exist in endothelial cells

A

Tight junctions

Adherens junctions

30
Q

Features of endothelial cell junctions

A

Homophilic interaction mediates adhesion between the cells and intravellular signalling
Also survival

31
Q

How do tumours achieve new vessel formation

A

They release angiogenic factors which initiates growth of sprouting capillary towards the tumour

32
Q

Features of tumour blood vessels

A

Irregularly shaped, torted and dilated
Not clearly organised into capillaries, arterioles and venues
Leaky and haemorrhagic
Perivascualr cells loosely associated

33
Q

Reason for leaky nature of tumour blood vessels

A

Overproduction of VEGF and loose association of pericytes

34
Q

Effects of tumours on platelets

A

Aggregation, activation and degranulation

35
Q

Overall outcome of platelet activation on tumours

A

Pro-angiogenic

36
Q

Reason for leaky nature of tumour vessels

A

High VEGF

37
Q

Alternative name for avastin

A

Bevacizumab